Rakuten Investment Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.84M Buy
18,058
+1,671
+10% +$328K 0.01% 323
2026
Q1
$3.23M Buy
16,387
+1,729
+12% +$336K 0.01% 322
2025
Q4
$2.57M Sell
14,658
-10,072
-41% -$1.83M 0.01% 404
2025
Q3
$2.04M Buy
+24,730
New +$4.39M 0.01% 407
2025
Q1
$1.7M Buy
+10,163
New +$1.67M 0.01% 408
2024
Q3
$976K Buy
6,303
+1,578
+33% +$236K 0.01% 352
2024
Q2
$649K Buy
4,725
+1,728
+58% +$237K ﹤0.01% 355
2024
Q1
$399K Buy
2,997
+2,719
+978% +$353K ﹤0.01% 365
2023
Q4
$38.3K Buy
+278
New +$36.5K ﹤0.01% 342

Other funds holding DGX

Rakuten Investment Management's DGX Position: Q2 2026 in Review

Rakuten Investment Management increased its Quest Diagnostics (DGX) stake by 10% in Q2 2026, buying an estimated $328K and bringing the position to 18,058 shares worth $3.84M. The position accounts for 0.01% of the portfolio, ranked #323.

Rakuten Investment Management first reported a position in DGX in Q4 2023 and has held it in 9 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Rakuten Investment Management held 18,058 shares of Quest Diagnostics worth $3.84M as of Q2 2026.
  • Rakuten Investment Management bought 1,671 Quest Diagnostics shares in Q2 2026, an estimated $328K.
  • Quest Diagnostics made up 0.01% of Rakuten Investment Management's portfolio in Q2 2026, its #323 holding.
  • Rakuten Investment Management first reported a position in Quest Diagnostics in Q4 2023 and has held it in 9 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Rakuten Investment Management's 13F filing for Q2 2026, filed 18 Aug 2026.